Skip to main content

Blepharitis News

AI Model Can Respond Appropriately to Ophthalmology Questions

FRIDAY, Aug. 25, 2023 – Large language models (LLMs) like ChatGPT can respond to patient-written ophthalmology questions and usually generate appropriate responses, according to a study published...

FDA Approves Xdemvy for Demodex Blepharitis

FRIDAY, July 28, 2023 – The U.S. Food and Drug Administration has approved Xdemvy (lotilaner ophthalmic solution) 0.25 percent for the treatment of Demodex blepharitis, caused by Demodex mites. The...

FDA Approves Xdemvy (lotilaner) Ophthalmic Solution for the Treatment of Demodex Blepharitis

IRVINE, Calif., July 25, 2023 (GLOBE NEWSWIRE) – Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), whose mission is to focus on unmet needs and apply proven science and new technology to revolutionize...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Eye Conditions